Insights from ESMO Breast 2024 Annual Meeting
ESMO Breast 2024 Insights: "Is There a Role for Combining PARP Inhibition With ET and Checkpoint Inhibition in HR+/HER2- mBC?"
Login to view comments.
Click here to Login
Videos